ReviewCurrent diabetes reports2016
Operational Components of Telemedicine Programs for Diabetic Retinopathy.
Review in Current diabetes reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 24 citations in OpenAlex.
- Remote Monitoring of Patients with Retinal Vein Occlusions Treated with Anti-VEGF: A Pilot Study.Journal of clinical medicine · 2025Article
- Enhancing diabetic retinopathy screening: Non-mydriatic fundus photography-assisted telemedicine for improved clinical management.World journal of diabetes · 2024Article
- INTEGRATING MACULAR OPTICAL COHERENCE TOMOGRAPHY WITH ULTRAWIDE-FIELD IMAGING IN A DIABETIC RETINOPATHY TELEMEDICINE PROGRAM USING A SINGLE DEVICE.Retina (Philadelphia, Pa.) · 2023Article
- Imaging Modalities Employed in Diabetic Retinopathy Screening: A Review and Meta-Analysis.Diagnostics (Basel, Switzerland) · 2021Review
- Integrating Telemedicine Services in Ophthalmology: Evaluating Patient Interest and Perceived Benefits.Patient preference and adherence · 2021Article
- The Indian Health Service Primary Care-Based Teleophthalmology Program for Diabetic Eye Disease Surveillance and Management.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2020Article
- Artificial intelligence in ophthalmology during COVID-19 and in the post COVID-19 era.Current opinion in ophthalmology · 2020Review
- Commentary: Telemedicine in ophthalmology: No distance too far, no future too distant.Indian journal of ophthalmology · 2020Article
- The unique association between the level of peripheral blood monocytes and the prevalence of diabetic retinopathy: a cross-sectional study.Journal of translational medicine · 2020Article
- Practice Guidelines for Ocular Telehealth-Diabetic Retinopathy, Third Edition.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2020Article
- Scaling Up Teleophthalmology for Diabetic Eye Screening: Opportunities for Widespread Implementation in the USA.Current diabetes reports · 2019Review
- Evaluation of a Remote Diagnosis Imaging Model vs Dilated Eye Examination in Referable Macular Degeneration.JAMA ophthalmology · 2019Article
- Payment Reform Needed to Address Health Disparities of Undiagnosed Diabetic Retinopathy in the City of Chicago.Ophthalmology and therapy · 2017Article
- Therapeutic Potential of Dimethyl SulfoxideIn vivo (Athens, Greece)Article
- Visual Function Measurements in Eyes With Diabetic Retinopathy: An Expert Opinion on Available Measures.Ophthalmology scienceReview
- Incidence of Referable Retinal Disease in Diabetic Patients at a Primary Care Practice.Journal of vitreoretinal diseasesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic retinopathy is a leading cause of new-onset vision loss worldwide. Treatments supported by large clinical trials are effective in preserving vision, but many persons do not receive timely diagnosis and treatment of diabetic retinopathy, which is typically asymptomatic when most treatable. Telemedicine evaluation to identify diabetic retinopathy has the potential to improve access to care and improve outcomes, but incomplete implementation of published standards creates a risk to program utility and sustainability. In a prior article, we reviewed the literature regarding the impact of imaging device, number and size of retinal images, pupil dilation, type of image grader, and diagnostic accuracy on telemedicine assessment for diabetic retinopathy. This article reviews the literature regarding the impact of automated image grading, cost effectiveness, program standards, and quality assurance (QA) on telemedicine assessment of diabetic retinopathy. Telemedicine assessment of diabetic retinopathy has the potential to preserve vision, but greater attention to development and implementation of standards is needed to better realize its potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.